Emerging MRI biomarkers improve diagnostic specificity and prognostication in multiple sclerosis, suggesting new ways to enhance patient care.
Emerging MRI biomarkers of multiple sclerosis that directly correlate with underlying pathophysiologic processes hold great promise for improving diagnostic specificity and prognostication.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: